With 2026 rates already set and consumers starting to learn of premium increases, delays in extending the PTC enhancements ...

Understanding the needs of high-need, high-cost community-based beneficiaries, including homebound status, will help Medicare ...

Researchers and physician scientists who accept private funding from profit-motivated actors must take affirmative steps to ...

The final guidance for the 2028 cycle of the Medicare drug price negotiation reflects CMS’s continued effort to balance ...

We contrast the differences between the traditional model of vaccine federalism and the emerging paradigms introduced by the ...

When implemented in state employee health plans, reference-based hospital price caps have the potential to save states money ...

Information disclosed under the “Patients Deserve Price Tags Act” will drive systemic change only to the extent that ...

Health Affairs' Rob Lott interviews Tris Dyson, Founder of Challenge Works on his efforts in cultivating challenge prizes as ...

Additional federal restrictions on mifepristone—whether imposed by the courts or the Trump administration in the future—would ...

Outbreaks of mpox have now been reported in more than a dozen countries across Africa, revealing a continent-wide surge just ...

Critical populations such as those experiencing homelessness or housing instability, involved in the child welfare system, or ...

Health Affairs' Jeff Byers welcomes Troyen A. Brennan of Harvard T.H. Chan School of Public Health and former CMO at CVS ...